Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Comment by Momentum11on Feb 14, 2017 12:22pm
82 Views
Post# 25843658

RE:RE:RE:RE:Question for Smartinvesting1

RE:RE:RE:RE:Question for Smartinvesting1
C12Returns wrote: Nonesense.  What's the big secret?  This is the last transparent company on the CSE.  

How do you ge to $24M in revenue?  This is a simple question.

doctordeacon wrote: you guys are bothering Catherine with your dumb questions and sexual angst ,hit the road sell your 20,000 shares if you dont like it here .
This will be a $1.40 stock based on price to earnings metrics that a grade 10 kid could grasp .




The way the 24 million is now worded on the website makes sense. "Potential revenue for our tenant" I assume its a basic calculation on their expected yields multiplied by $/gram which is accurate. Based on the state data and how much companies are able to sell I don't think its realistic, you can grow all you want but you have to be able to sell it. It is wrong on the presentation though as I pointed out.
Bullboard Posts